Clinical Site definition

Clinical Site. A physical area where clinical education occurs.
Sample 1Sample 2
Clinical Site means a site or institution that will participate in performance of the Study.
Sample 1
Clinical Site. Use the full, correct name as listed in “Schedule of Option Availability”. In: Enter the time recorded by site personnel from the appropriate “Clinical Site Documentation” form. Be sure to indicate AM or PM. Out: Same as “In”.
Sample 1

Examples of Clinical Site in a sentence

  • Clinical Site Manager (CSM) CSM will have access to IP supply, accountability logs, and other documents or supplies pertaining to IP accountability.

  • Clinical Site and Preceptor Evaluation Clinical site and Preceptor evaluations are to be completed by the student at the end of each clinical experience.


More Definitions of Clinical Site

Clinical Site means a hospital, outpatient department, clinic, radiology practice, an office of a physician and surgeon, podiatrist or chiropractor, or any other place or building in which a person conducts radiologic technology.
Sample 1
Clinical Site refers to the City of Xxxxx’x Xxxxx Animal Center, located at 0000 Xxxxxxxxxx Xxxx.
Sample 1
Clinical Site means a third party that administers Contact, Screening and Enrollment of Eligible Patients for Clinical Research Trials.
Sample 1
Clinical Site means an acute care or rehabilitation facility, a primary care setting, a long-term care facility, a nursing home, a residential care setting, or any other site identified by the board as providing clinical learning experiences for nursing students.
Sample 1

Related to Clinical Site

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Cell Site means a transmitter/receiver location, operated by a CMRS provider, through which radio links are established between a wireless system and a Wireless Phone Handset.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information: